期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
In silico Analysis of the Potential Infection Mechanisms of Magnaporthe grisea from Horizontal Gene Transfer Hypothesis
1
作者 Chunyang Li Ying Wang +5 位作者 Hao Peng Hejiao Bian Mingwei Min Longfei Chen Qian Liu Jinku Bao 《Genomics, Proteomics & Bioinformatics》 SCIE CAS CSCD 2009年第3期77-86,共10页
Horizontal gene transfer (HGT) has long been considered as a principal force for an organism to gain novel genes in genome evolution. Homology search, phylogenetic analysis and nucleotide composition analysis are th... Horizontal gene transfer (HGT) has long been considered as a principal force for an organism to gain novel genes in genome evolution. Homology search, phylogenetic analysis and nucleotide composition analysis are three major objective approaches to arguably determine the occurrence and directionality of HGT. Here, 21 genes that possess the potential to horizontal transfer were acquired from the whole genome of Magnaporthe grisea according to annotation, among which three candidate genes (corresponding protein accession numbers are EAA55123, EAA47200 and EAA52136) were selected for further analysis. According to BLAST homology results, we subsequently conducted phylogenetic analysis of the three candidate HGT genes. Moreover, nucleotide composition analysis was conducted to further validate these HGTs. In addition, the functions of the three candidate genes were searched in COG database. Consequently, we conclude that the gene encoding protein EAA55123 is transferred from Clostridium perfringens. Another HGT event is between EAA52136 and a certain metazoan's corresponding gene, but the direction remains uncertain. Yet, EAA47200 is not a transferred gene. 展开更多
关键词 Magnaporthe grisea infection mechanism horizontal gene transfer HOMOLOGY phylogenetic analysis nucleotide composition
原文传递
Genomic variation,origin tracing,and vaccine development of SARS-CoV-2:A systematic review 被引量:2
2
作者 Tianbao Li Tao Huang +9 位作者 Cheng Guo Ailan Wang Xiaoli Shi Xiaofei Mo Qingqing Lu Jing Sun Tingting Hui Geng Tian Leyi Wang Jialiang Yang 《The Innovation》 2021年第2期84-94,共11页
COVID-19 has spread globally to over 200 countries with more than 40 million confirmed cases and one million deaths as of November 1,2020.The SARS-CoV-2 virus,leading to COVID-19,shows extremely high rates of infectiv... COVID-19 has spread globally to over 200 countries with more than 40 million confirmed cases and one million deaths as of November 1,2020.The SARS-CoV-2 virus,leading to COVID-19,shows extremely high rates of infectivity and replication,and can result in pneumonia,acute respiratory distress,or even mortality.SARS-CoV-2 has been found to continue to rapidly evolve,with several genomic variants emerging in different regions throughout the world.In addition,despite intensive study of the spike protein,its origin,and molecular mechanisms in mediating host invasion are still only partially resolved.Finally,the repertoire of drugs for COVID-19 treatment is still limited,with several candidates still under clinical trial and no effective therapeutic yet reported.Although vaccines based on either DNA/mRNA or protein have been deployed,their efficacy against emerging variants requires ongoing study,with multivalent vaccines supplanting the first-generation vaccines due to their low efficacy against new strains.Here,we provide a systematic review of studies on the epidemiology,immunological pathogenesis,molecular mechanisms,and structural biology,as well as approaches for drug or vaccine development for SARSCoV-2. 展开更多
关键词 COVID-19 SARS-CoV-2 origin tracing infection mechanism SARS-CoV-2 vaccine
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部